Nicole V Johnson
Overview
Explore the profile of Nicole V Johnson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
2074
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wasdin P, Johnson N, Janke A, Held S, Marinov T, Jordaan G, et al.
bioRxiv
. 2025 Mar;
PMID: 40027781
The traditional process of antibody discovery is limited by inefficiency, high costs, and low success rates. Recent approaches employing artificial intelligence (AI) have been developed to optimize existing antibodies and...
2.
Johnson N, Wall S, Kramer K, Holt C, Periasamy S, Richardson S, et al.
Structure
. 2024 Sep;
32(11):1893-1909.e11.
PMID: 39326419
The continued emergence of deadly human coronaviruses from animal reservoirs highlights the need for pan-coronavirus interventions for effective pandemic preparedness. Here, using linking B cell receptor to antigen specificity through...
3.
Sponholtz M, Byrne P, Lee A, Ramamohan A, Goldsmith J, McCool R, et al.
Proc Natl Acad Sci U S A
. 2024 Sep;
121(37):e2404250121.
PMID: 39231203
Human cytomegalovirus (HCMV) glycoprotein B (gB) is a class III membrane fusion protein required for viral entry. HCMV vaccine candidates containing gB have demonstrated moderate clinical efficacy, but no HCMV...
4.
Johnson N, van Scherpenzeel R, Bakkers M, Ramamohan A, van Overveld D, Le L, et al.
Nat Commun
. 2024 Jun;
15(1):5458.
PMID: 38937429
Respirovirus 3 is a leading cause of severe acute respiratory infections in vulnerable human populations. Entry into host cells is facilitated by the attachment glycoprotein and the fusion glycoprotein (F)....
5.
Langedijk J, Cox F, Johnson N, van Overveld D, Le L, van den Hoogen W, et al.
Nat Commun
. 2024 May;
15(1):4629.
PMID: 38821950
The Paramyxoviridae family encompasses medically significant RNA viruses, including human respiroviruses 1 and 3 (RV1, RV3), and zoonotic pathogens like Nipah virus (NiV). RV3, previously known as parainfluenza type 3,...
6.
Johnson N, Wall S, Kramer K, Holt C, Periasamy S, Richardson S, et al.
bioRxiv
. 2024 Jan;
PMID: 38293237
Three coronaviruses have spilled over from animal reservoirs into the human population and caused deadly epidemics or pandemics. The continued emergence of coronaviruses highlights the need for pan-coronavirus interventions for...
7.
Shiakolas A, Kramer K, Johnson N, Wall S, Suryadevara N, Wrapp D, et al.
Nat Biotechnol
. 2022 Mar;
40(8):1270-1275.
PMID: 35241839
Although several monoclonal antibodies (mAbs) targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been approved for coronavirus disease 2019 (COVID-19) therapy, development was generally inefficient, with lead generation often...
8.
Schaub J, Chou C, Kuo H, Javanmardi K, Hsieh C, Goldsmith J, et al.
Nat Protoc
. 2021 Oct;
16(11):5339-5356.
PMID: 34611365
The severe acute respiratory syndrome coronavirus 2 spike protein is a critical component of coronavirus disease 2019 vaccines and diagnostics and is also a therapeutic target. However, the spike protein...
9.
Kramer K, Johnson N, Shiakolas A, Suryadevara N, Periasamy S, Raju N, et al.
Cell Rep
. 2021 Sep;
37(1):109784.
PMID: 34592170
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineages that are more transmissible and resistant to currently approved antibody therapies poses a considerable challenge to the clinical treatment...
10.
Andreano E, Piccini G, Licastro D, Casalino L, Johnson N, Paciello I, et al.
Proc Natl Acad Sci U S A
. 2021 Aug;
118(36).
PMID: 34417349
To investigate the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the immune population, we coincupi bated the authentic virus with a highly neutralizing plasma from a COVID-19...